H&E staining (Figure 7, A), the steatosis and inflammation scores, liver TGs, serum ALT activity, portal serum FITC-dextran (Figure 7, B), hepatic bacterial 16S rRNA (Figure 7, C), and hepatic mRNA expression of pro-inflammatory cytokines (Figure 7, D) revealed less liver injury in ethanol-fed WT with oral administration of mOPN in the presence or absence of FMT from ethanol-fed WT mice. The gene discussed is GPT; the disease is steatosis.